. Author manuscript; available in PMC: 2024 May 1.

Published in final edited form as: J Magn Reson Imaging. 2022 Sep 27;57(5):1552–1564. doi: 10.1002/jmri.28439

Table 3.

Cognitive Performance at baseline and after one-month treatment (mean ± standard error) in non-adaptive group.

Cognitive z-scores	TL1 (n = 48)			TL2 (n = 48)
Cognitive z-scores	SN (n = 25)	PWH (n = 23)	p	SN (n = 25)	PWH (n = 23)	p
Fluency	−0.13±0.14	−0.29±0.19	0.504	−0.08±0.13	−0.38±0.17	0.171
Executive function	−0.11±0.16	−0.25±0.13	0.521	−0.03±0.15	−0.24±0.17	0.237
Speed	−0.30±0.14	−0.27±0.15	0.906	−0.05±0.18	−0.27±0.16	0.364
Attention	−0.24±0.14	−0.41±0.14	0.392	−0.13±0.16	−0.24±0.13	0.602
Learning	−0.10±0.18	−0.35±0.20	0.370	−0.01±0.16	−0.17±0.21	0.526
Memory	0.04±0.20	−0.12±0.20	0.560	0.20±0.19	−0.14±0.20	0.212

SN: seronegative controls; PWH: people with human immunodeficiency virus; TL1: baseline; TL2: one-month after treatment; n: number of participants; p: from two-sample t-test between PWH and SN.